South Africa Antidiabetics Market Size & Outlook, 2023-2030
The antidiabetics market in South Africa is expected to reach a projected revenue of US$ 527.5 million by 2030. A compound annual growth rate of 6.3% is expected of South Africa antidiabetics market from 2024 to 2030.
Revenue, 2023 (US$M)
$345.0
Forecast, 2030 (US$M)
$527.5
CAGR, 2024 - 2030
6.3%
Report Coverage
South Africa
South Africa antidiabetics market, 2018-2030 (US$M)
Related Markets
South Africa antidiabetics market highlights
- The South Africa antidiabetics market generated a revenue of USD 345.0 million in 2023 and is expected to reach USD 527.5 million by 2030.
- The South Africa market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, glp-1 receptor agonists was the largest revenue generating drug class in 2023.
- GLP-1 Receptor Agonists is the most lucrative drug class segment registering the fastest growth during the forecast period.
Antidiabetics market data book summary
| Market revenue in 2023 | USD 345.0 million |
| Market revenue in 2030 | USD 527.5 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Glp-1 receptor agonists |
| Fastest growing segment | GLP-1 Receptor Agonists |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Others Drug Class, Insulin |
| Key market players worldwide | AstraZeneca PLC, Bayer AG, Takeda Pharmaceutical Co Ltd, Eli Lilly and Co, Boehringer Ingelheim, Bristol-Myers Squibb Co, Pfizer Inc, Johnson & Johnson, Merck & Co Inc, Novartis AG ADR |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.5% of the global antidiabetics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia antidiabetics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 298.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antidiabetics Market Scope
Antidiabetics market segmentation & scope
Antidiabetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa antidiabetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antidiabetics market will help companies and investors design strategic landscapes.
Glp-1 receptor agonists was the largest segment with a revenue share of 35.36% in 2023. Horizon Databook has segmented the South Africa antidiabetics market based on glp-1 receptor agonists, dpp- 4 inhibitors, sglt2 inhibitors, others drug class, insulin covering the revenue growth of each sub-segment from 2018 to 2030.
- South Africa Antidiabetics Drug Class Outlook (Revenue, USD Million, 2018-2030)
- GLP-1 Receptor Agonists
- DPP- 4 Inhibitors
- SGLT2 Inhibitors
- Others Drug Class
- Insulin
- Long-acting insulin
- Premix insulin
- Fast-acting insulin
- Human insulin
- South Africa Antidiabetics Diabetes Type Outlook (Revenue, USD Million, 2018-2030)
- Type 1
- Type 2
- South Africa Antidiabetics Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South Africa Antidiabetics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Subcutaneous
- Intravenous
Reasons to subscribe to South Africa antidiabetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa antidiabetics market databook
-
Our clientele includes a mix of antidiabetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa antidiabetics market, including forecasts for subscribers. This country databook contains high-level insights into South Africa antidiabetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa antidiabetics market size, by drug class, 2018-2030 (US$M)
South Africa Antidiabetics Market Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
